
暂无股票
Avrobio up 69% on Plans to Sell Gene Therapy Program to Novartis
Is Novartis AG's (VTX:NOVN) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Novartis Appoints 10-member Board for Sandoz Unit Ahead of Spinoff
Allakos Gains as Jefferies Upgrades to Buy on Lead Candidate
Novartis AG (NYSE:NVS) Q1 2023 Earnings Call Transcript
Novartis AG (VTX:NOVN) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
Novartis AG Says Novartis Cosentyx Gains Positive CHMP Opinion For Hidradenitis Suppurativa; Opinion Paves Way For First New Treatment Option In Hidradenitis Suppurativa In Nearly A Decade; Regulatory Decision From U.S. FDA Expected Later This Year
诺华股份公司表示,Novartis Cosentyx获得CHMP对化脓性汗腺炎的积极看法;意见为近十年来化脓性汗腺炎的首个新治疗选择铺平了道路;监管部门
Research Alert: CFRA Maintains Hold Opinion On Adss Of Novartis Ag
美国东部时间2023年4月26日凌晨 04:10(MT Newswires)——独立研究提供商CFRA已向MT Newswires提供了以下研究提醒。CFRA的分析师将他们的观点总结如下
Novartis AG Raises Q1 Sales Growth Guidance To Mid-single Digits (From Low-to-mid Single Digits)
诺华股份公司将第一季度销售增长指引上调至中个位数(从低到中个位数)
Novartis AG 1Q Net Pft $2.3B
诺华股份公司第一季度净利润23亿美元
加载中...
暂无股票